APA (7th ed.) Citation

A, C., R, A., R, S., I, D., B, R., S, M., . . . F, G. (2021). Pro64His (rs4644) Polymorphism Within Galectin-3 Is a Risk Factor of Differentiated Thyroid Carcinoma and Affects the Transcriptome of Thyrocytes Engineered via CRISPR/Cas9 System. Thyroid : official journal of the American Thyroid Association, 31(7), 1056. https://doi.org/10.1089/thy.2020.0366

Chicago Style (17th ed.) Citation

A, Corrado, et al. "Pro64His (rs4644) Polymorphism Within Galectin-3 Is a Risk Factor of Differentiated Thyroid Carcinoma and Affects the Transcriptome of Thyrocytes Engineered via CRISPR/Cas9 System." Thyroid : Official Journal of the American Thyroid Association 31, no. 7 (2021): 1056. https://doi.org/10.1089/thy.2020.0366.

MLA (9th ed.) Citation

A, Corrado, et al. "Pro64His (rs4644) Polymorphism Within Galectin-3 Is a Risk Factor of Differentiated Thyroid Carcinoma and Affects the Transcriptome of Thyrocytes Engineered via CRISPR/Cas9 System." Thyroid : Official Journal of the American Thyroid Association, vol. 31, no. 7, 2021, p. 1056, https://doi.org/10.1089/thy.2020.0366.